Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03XUQ
|
||||
Former ID |
DIB007317
|
||||
Drug Name |
ABS-212
|
||||
Synonyms |
Neurotensin derivative (pain), Argolyn
|
||||
Company |
Argolyn Bioscience Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[C@@H]1(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)[O-])C<br />C(C)C)C(C)(C)C)Cc2ccc(cc2)O)CCCN1C(=O)[C@@H](NC(=O)[C@H<br />](CCC[N+](C)(C)C)C)CCCNC(=N)N
|
||||
Target and Pathway | |||||
Target(s) | Neurotensin receptor type 1 | Target Info | Agonist | [530926] | |
References | |||||
Ref 540761 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5307). | ||||
Ref 548547 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026502) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.